DS-6157a
Showing 1 - 25 of 7,442
Gastrointestinal Stromal Tumors Trial in Japan, United States (DS-6157a)
Completed
- Gastrointestinal Stromal Tumors
- DS-6157a
-
Boston, Massachusetts
- +4 more
Apr 7, 2022
Advanced Solid Tumor, Metastatic Solid Tumor Trial (DS-3939a)
Not yet recruiting
- Advanced Solid Tumor
- Metastatic Solid Tumor
- (no location specified)
May 12, 2023
Netherton Syndrome Trial in Paris (DS-2325a, Placebo)
Not yet recruiting
- Netherton Syndrome
- DS-2325a
- Placebo
-
Paris, FranceSaint Louis Hospital
Jul 31, 2023
Cholangioscopy With Spyglass DS Using Percutaneous Transhepatic
Completed
- Biliary Stricture
- Spy PTC
- (no location specified)
Oct 17, 2023
Malignant Solid Tumor, Metastatic EphA2 Positive Cancer Trial in Heidelberg (DS-8895a 1 mg/kg, DS-8895a 3 mg/kg, DS-8895a 10
Completed
- Malignant Solid Tumor
- Metastatic EphA2 Positive Cancer
- DS-8895a 1 mg/kg
- +2 more
-
Heidelberg, Victoria, AustraliaAustin Health
Oct 3, 2022
Netherton Syndrome Trial in San Antonio (DS-2325a, Placebo)
Recruiting
- Netherton Syndrome
- DS-2325a
- Placebo
-
San Antonio, TexasWorldwide Clinical Trials
Nov 29, 2022
Endometrial Serous Adenocarcinoma, Metastatic Malignant Solid Tumor, Unresectable Malignant Solid Tumor Trial in United States
Recruiting
- Endometrial Serous Adenocarcinoma
- +2 more
- Biopsy
- +3 more
-
Phoenix, Arizona
- +3 more
Feb 2, 2023
Adenocarcinoma, Gastric, Tumor, Breast Trial in Taipei (DS-8201a)
Completed
- Adenocarcinoma, Gastric
- Neoplasm, Breast
-
Taipei, Taiwan
- +1 more
Nov 2, 2022
HER2-Positive Breast Carcinoma, Metastatic Malignant Solid Tumor, Refractory Malignant Solid Tumor Trial in United States
Recruiting
- Advanced Malignant Solid Neoplasm
- +4 more
- Biopsy
- +3 more
-
Bethesda, Maryland
- +4 more
Jan 21, 2023
Diabetes, Diabetic Retinopathy Trial in Fayetteville, Orlando, Jackson (AEYE-DS Software)
Recruiting
- Diabetes Mellitus
- Diabetic Retinopathy
- AEYE-DS Software
-
Fayetteville, Arkansas
- +2 more
May 4, 2023
Covid19 Trial in Hakata (DS-5670a, Placebo)
Completed
- Covid19
- DS-5670a
- Placebo
-
Hakata, Fukuoka, JapanSOUSEIKAI Hakata Clinic
Aug 29, 2022
Fibrodysplasia Ossificans Progressiva Trial in Osaka (DS-6016a, Placebo)
Completed
- Fibrodysplasia Ossificans Progressiva
- DS-6016a
- Placebo
-
Osaka, JapanMedical Corporation Heishinkai OPHAC Hospital
Aug 2, 2022
Systemic Lupus Erythematosus, Cutaneous Lupus Erythematosus Trial (DS-7011a, Placebo)
Not yet recruiting
- Systemic Lupus Erythematosus
- Cutaneous Lupus Erythematosus
- DS-7011a
- Placebo
- (no location specified)
Dec 12, 2022
Advanced Solid Tumors Trial in Japan, United States (DS-8201a (DP1), DS-8201a (DP2), DS-8201a (DP))
Active, not recruiting
- Advanced Solid Tumors
- DS-8201a (DP1)
- +2 more
-
San Diego, California
- +13 more
Oct 4, 2022
Ventral Hernia Trial in United States (Parietene DS Composite Mesh)
Completed
- Ventral Hernia
- Parietene DS Composite Mesh
-
Lexington, Kentucky
- +6 more
Oct 25, 2022
Breast Cancer Stage IV Trial in Vienna (Trastuzumab deruxtecan)
Active, not recruiting
- Breast Cancer Stage IV
- Trastuzumab deruxtecan
-
Vienna, AustriaAKH Universitaetsklinikum Vienna, Department f. Internal medicin
Jul 26, 2022
Acute Ischemic Stroke Trial in Barcelona (Thrombectomy)
Recruiting
- Acute Ischemic Stroke
- Thrombectomy
-
Barcelona, SpainHospital Universitario Vall d'Hebrón
Nov 18, 2022
Depressive Symptoms, Diabetes Trial in Bad Mergentheim (Diabetes-Specific CBT (DS-CBT), Standard Diabetes Education)
Completed
- Depressive Symptoms
- Diabetes Mellitus
- Diabetes-Specific CBT (DS-CBT)
- Standard Diabetes Education
-
Bad Mergentheim, Baden-Württemberg, GermanyForschungsinstitut der Diabetes Akademie Mergentheim e. V.
Sep 9, 2022